How to Buy Indivior Pharmaceuticals Stock
Indivior Pharmaceuticals Inc
Indivior Pharmaceuticals Inc is a holding company, which engages in the development, manufacture and sale of buprenorphine-based prescription drugs for treatment of opioid dependence.
Indivior Pharmaceuticals stock last closed at $33.89, down 1.6% from the previous day, and has increased 276.97% in one year. It has overperformed other stocks in the Drug Manufacturers - Specialty & Generic industry by 3.03 percentage points. Indivior Pharmaceuticals stock is currently +344.75% from its 52-week low of $7.62, and -10.82% from its 52-week high of $38.00.
At the moment, there are 124.85M INDV shares outstanding. The market capitalization of INDV is $4.23B. In the last 24 hours, 1.4M INDV shares were traded.
How to Buy Indivior Pharmaceuticals Stock
Wondering how to invest in Indivior Pharmaceuticals stock? Here's how.
- Figure out where to buy Indivior Pharmaceuticals stock: You need to choose a stock brokerage, but don't worry - we've tested dozens of online stock brokerages and apps to help you choose where to buy Indivior Pharmaceuticals stock.
- Open your brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've identified.
- Put funds into your brokerage account: Choose your payment method and add your information.
- Research Indivior Pharmaceuticals stock: The Indivior Pharmaceuticals ticker symbol is INDV. Is Indivior Pharmaceuticals stock a good investment? Should you buy shares of INDV? How do INDV's underlying business fundamentals look? Do top analysts think Indivior Pharmaceuticals is a good buy? Why has INDV's stock price moved recently? (Hint: Our stock market research website can help you evaluate if INDV is a good stock to buy).
- Make your INDV buy order: Decide if you will purchase INDV shares at the current market price or use a limit order to buy INDV shares at a given price.
- Get the latest news on your investment in INDV: Create a watchlist to keep tabs on your investment in Indivior Pharmaceuticals shares.
Step 1: Figure out where to buy Indivior Pharmaceuticals stock
You will need a brokerage account to access the NASDAQ market and buy INDV stock.
Our favorite brokerage: eToro
Based on our experience, eToro is the best online stock brokerage. Here's why:
- You can invest in stocks with zero commissions: Invest without paying trading commissions.
- Buy fractional shares: Even if you can't afford a full share, you can still purchase the stock.
- Access to world markets: From Technology to Industrials, New York to Tokyo (for US users, only US stocks are available) — you can fill your portfolio with stocks from the globe's leading exchanges.
- Social investing: eToro offers a community with more than 20 million users worldwide. Talk to, learn from, and copy the crypto trades of other investors.
- Security: eToro is a regulated and licensed fintech leader.
- Buy other assets: Such as ETFs and cryptos.
Get $10 towards your share purchase by signing up for an account with eToro now. This offer is only for US users.
Open eToro AccountStep 2: Open your brokerage account
Now that you've chosen your brokerage, you'll need to fill out some personal info so you can invest in INDV stock today.
How to Open a New Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Provide your personal data to start a new brokerage account.
- Submit your info by clicking the "Create Account" button. Get started with eToro today
Step 3: Put funds into your brokerage account
Now that you have filled out your info on stock apps to use, you need to deposit funds:
Watch the video below for more details depositing funds into your investment account.
Step 4: Research Indivior Pharmaceuticals stock
After you have figured out the best place to buy Indivior Pharmaceuticals stock, it's critical to analyze their stock prior to investing, so you can comprehend the risk as well as the upside.
Overview of key INDV info
INDV Fundamentals
WallStreetZen was built to help average investors do better fundamental analysis in minutes instead of hours.
You can view all of the due diligence checks on INDV's stock page.
How is INDV stock valued?
Investors use a variety of different financial metrics, analyses, models, and charts to gauge INDV's true value.
Using relative valuations methods:
- INDV could be undervalued based on its P/E ratio of 25.87x, relative to Drug Manufacturers - Specialty & Generic industry P/E ratio of -134.01x
- INDV could be undervalued based on its PEG ratio of 0.65x
You can do additional valuation analysis on INDV's stock here.
INDV Financial Health
Positive Health Checks:
- INDV profit margin has gone up from -7.7% to 14.1% in the past year.
- INDV's operating cash flow of $136.00M allows it to safely service it's debt of $356.00M.
- There are more short-term assets than long-term liabilities on the INDV balance sheet.
- INDV earnings of $296.00M is not enough to cover its interest payments.
Negative Health Checks:
- There are more short-term liabilities than short-term assets on the INDV balance sheet.
- Total INDV debt is still negative.
- INDV debt to equity ratio of -7.84 is negative.
Is it a good time to buy Indivior Pharmaceuticals stock, according to analysts?
Out of 3 Equities analysts who give recommendations on INDV, the consensus analyst rating on Indivior Pharmaceuticals is a Strong Buy
It's important to note that analyst ratings are not recommendations, nor are they financial advice.
You can dig deeper into what analysts are forecasting on the Indivior Pharmaceuticals stock forecast page.
Metrics for Advanced INDV Traders
How is INDV performing as a company?
Last year, INDV revenue was $1.18B. Over the past two year, INDV's revenue has grown by 6.46% per year. This was slower than the Drug Manufacturers - Specialty & Generic industry average of 6.97%.
You can analyze INDV's earnings and revenue performance here.
Who is buying/selling INDV?
Over the past year, insiders at INDV have bought more shares than they have sold.
Keith Humphreys, Director of INDV, was the latest INDV insider to buy. They bought $27,429.58 worth of INDV stock on Jan 5, 2026.
Dig into more about who owns INDV shares here.
Does INDV provide a stable income stream?
No, Indivior Pharmaceuticals doesn't provide an income stream by paying out dividends.
What do other traders have to say about INDV?
One of the reasons eToro is our top-rated brokerage is because of its social trading community.
Click below to learn what other traders have to say.
Step 5: Make your INDV buy order
There are two main options:
- Market order: A market order is an order to buy or sell a stock at the best price on the market.
Market orders are generally the best for newer investors. - Limit order: A limit order is an order to buy or sell a stock at a specific price (or better).
If you want to be certain you're buying or selling at an exact price limit, place a limit order.
Press the Open Trade button and your broker will execute the order.
If you require additional assistance buying stocks on eToro, watch the how to video below:
Step 6: Get the latest news on your investment in INDV
Now that you own some INDV stock, you'll want to stay up-to-date on your investment.
Start a watchlist to keep track of your INDV stock.
INDV Feed
How to Buy Stock in Indivior Pharmaceuticals
To summarize, here are the 6 steps for buying Indivior Pharmaceuticals stock:
- Figure out where to buy Indivior Pharmaceuticals stock
- Open your brokerage account
- Put funds into your brokerage account
- Research Indivior Pharmaceuticals stock
- Make your INDV buy order
- Get the latest news on your investment in INDV
If you require a online brokerage, eToro is our recommended option.
Get Started with eToro TodayIf you would like to get the latest news on your new investment in Indivior Pharmaceuticals, create a watchlist today.
Trending Articles
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.